Aspergillosis. Clinical forms and treatment

被引:31
作者
Fortun, Jesus [1 ]
Meije, Yolanda [1 ]
Fresco, Gema [1 ]
Moreno, Santiago [1 ]
机构
[1] Hosp Ramon & Cajal, Serv Enfermedades Infecciosas, E-28034 Madrid, Spain
来源
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2012年 / 30卷 / 04期
关键词
Aspergillosis; Clinical forms; Therapy; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ORGAN TRANSPLANT RECIPIENTS; INVASIVE FUNGAL-INFECTIONS; COMBINATION ANTIFUNGAL THERAPY; LIPOSOMAL AMPHOTERICIN-B; RISK-FACTORS; PULMONARY ASPERGILLOSIS; EUROPEAN ORGANIZATION; CELL TRANSPLANTATION; 1ST-LINE THERAPY;
D O I
10.1016/j.eimc.2011.12.005
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Invasive aspergillosis, chronic pulmonary aspergillosis and allergic bronchopulmonary aspergillosis are the clinical forms of aspergillosis. Although there is a great number of Aspergillus species, AspergiIlus fumigarus-complex is the more frequent aetiological agent, regardless of clinical form or baseline condition. The increase in immunosuppressive agents and the higher use of corticosteroids in chronic obstructive pulmonary disease have led to aspergillosis becoming more prominent in recent years. Galactomannan detection and radiological diagnostic images complement the limitations of microbiology cultures in these patients. Voriconazole and liposomal amphotericin 13 are the gold standard in patients requiring therapy, and posaconazole, itraconazole, caspofungin and other echinocandins are effective alternatives. The prognosis depends of clinical forms and characteristics of the host, but it is particularly poor in the disseminated invasive forms. (C) 2011 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:201 / 208
页数:8
相关论文
共 50 条
  • [21] Mild, moderate, and severe forms of allergic bronchopulmonary aspergillosis - A clinical and serologic evaluation
    Kumar, R
    CHEST, 2003, 124 (03) : 890 - 892
  • [22] Serial monitoring ofAspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples
    P. E. Verweij
    J. F. G. M. Meis
    E. C. Dompeling
    J. P. Donnelly
    A. V. M. B. Schattenberg
    Infection, 1997, 25 : 86 - 89
  • [23] Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis
    Jhun, Byung Woo
    Jeon, Kyeongman
    Eom, Jung Seop
    Lee, Ji Hyun
    Suh, Gee Young
    Kwon, O. Jung
    Koh, Won-Jung
    MEDICAL MYCOLOGY, 2013, 51 (08) : 811 - 817
  • [24] Clinical Application of Voriconazole Concentrations in the Treatment of Invasive Aspergillosis
    Howard, Ashley
    Hoffman, Janet
    Sheth, Anjly
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (12) : 1859 - 1864
  • [25] Prophylaxis and Treatment of Invasive Aspergillosis: Who and How of Prophylaxis, Treatment, and New Therapies
    Vergidis, Paschalis
    Denning, David W.
    CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES, 2020, 12 (01) : 54 - 70
  • [26] Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications
    Sherif, Rami
    Segal, Brahm H.
    CURRENT OPINION IN PULMONARY MEDICINE, 2010, 16 (03) : 242 - 250
  • [27] Allergic bronchopulmonary aspergillosis in asthma: epidemiological, clinical and therapeutic issues
    Agarwal, Ritesh
    Chakrabarti, Arunaloke
    FUTURE MICROBIOLOGY, 2013, 8 (11) : 1463 - 1474
  • [28] Aspergillosis: from diagnosis to treatment
    Uchoa Sales, Maria da Penha
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2009, 35 (12) : 1238 - 1244
  • [29] Pulmonary aspergillosis: diagnosis and treatment
    Lamoth, Frederic
    Calandra, Thierry
    EUROPEAN RESPIRATORY REVIEW, 2022, 31 (166)
  • [30] Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations
    Natesan, Suganthini Krishnan
    Chandrasekar, Pranatharthi H.
    INFECTION AND DRUG RESISTANCE, 2016, 9 : 291 - 300